Table 1. Clinical characteristics of the patients at baseline.
| Characteristic | Patients (n=9) | % |
|---|---|---|
| Mean age, years (range) | 40 | 29–63 |
| Sex (n, %) | ||
| Male | 9 | 100% |
| Female | 0 | 0% |
| Epidemiological risk factors and comorbidities (n, %) | ||
| Male sexual partners | 9 | 100% |
| Prior smallpox immunization | 0 | 0% |
| Median duration of symptoms before treatment, days (range) | 9 | 5–22 |
| Hospitalized | 3 | 33% |
| Suspected or proven bacterial superinfectiona | 6 | 66% |
| Human immunodeficiency virus | 5 | 55% |
| Median CD4 count of patients living with human immunodeficiency virus (cells/uL) | 513 | N/A |
| Median viral load | Undetectable | Undetectable |
| Symptoms (n, %) | ||
| Head and neck | 5 | 55% |
| Neurological | 2 | 22% |
| Genitourinary and anorectal | 5 | 55% |
| Fever | 5 | 55% |
| Lymphadenopathy | 9 | 100% |
| Myalgias | 3 | 33% |
Abbreviation: N/A, not applicable
a Culture proven Streptococcus pyogenes infection, including one peritonsillar abscess